Michael O'Brien CFA

Stock Analyst at Wolfe Research

(1.78)

# 3,191

Out of 4,396 analysts

4

Total ratings

50%

Success rate

10.1%

Average return

Main Sectors:

Technology Healthcare Industrials

Top Industries:

Software - Application Drug Manufacturers - General Rental & Leasing Services

Stocks Rated by Michael O'Brien CFA

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NATL NCR Atleos	Downgraded: Hold	n/a	$44.39	-	2	Feb 27, 2026
	BAYRY Bayer Aktiengesellschaft	Downgraded: Hold	n/a	$10.18	n/a	1	Jan 30, 2024
	VSTS Vestis	Initiated Coverage: Buy	$24	$12.87	n/a	1	Jan 11, 2024

NCR Atleos

Feb 27, 2026

Downgraded: Hold

Price Target: n/a

Current: $44.39

Upside: -

Bayer Aktiengesellschaft

Jan 30, 2024

Downgraded: Hold

Price Target: n/a

Current: $10.18

Upside: n/a

Vestis

Jan 11, 2024

Initiated Coverage: Buy

Price Target: $24

Current: $12.87

Upside: n/a